Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Sarah E. Hartmann"'
Autor:
Charlotte Lee, Zsofia D. Drobni, Amna Zafar, Carlos A. Gongora, Daniel A. Zlotoff, Raza M. Alvi, Jana Taron, Paula K. Rambarat, Sara Schoenfeld, Ramya C. Mosarla, Vineet K. Raghu, Sarah E. Hartmann, Hannah K. Gilman, Sean P. Murphy, Ryan J. Sullivan, Alexander Faje, Udo Hoffmann, Lili Zhang, Thomas Mayrhofer, Kerry L. Reynolds, Tomas G. Neilan
Publikováno v:
JACC: CardioOncology. 4:660-669
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::826a7a4a0550754cb1e6f4db0602f72c
https://doi.org/10.1016/j.jaccao.2022.11.008
https://doi.org/10.1016/j.jaccao.2022.11.008
Autor:
Carlos A. Gongora, Zsofia D. Drobni, Thiago Quinaglia Araujo Costa Silva, Amna Zafar, Jingyi Gong, Daniel A. Zlotoff, Hannah K. Gilman, Sarah E. Hartmann, Supraja Sama, Sofia Nikolaidou, Giselle Alexandra Suero-Abreu, Eric Jacobsen, Jeremy S. Abramson, Ephraim Hochberg, Jeffrey Barnes, Philippe Armand, Paaladinesh Thavendiranathan, Anju Nohria, Tomas G. Neilan
Publikováno v:
JACC. Heart failure. 10(8)
Sodium-glucose co-transporter-2 (SGLT2) inhibitors improve outcomes among patients with established heart failure. Despite supportive basic science studies, there are no data on the value of SGLT2 inhibitors among patients treated with anthracyclines
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::536f60dc91516e92075839e8b39b5ec3
https://pubmed.ncbi.nlm.nih.gov/35902160
https://pubmed.ncbi.nlm.nih.gov/35902160